High-performance liquid chromatographic assay for carboplatin in ultrafiltered plasma combined with hyperbaric oxygenation | Canada Hyperbarics Skip to main content
Study Drug Metab Pharmacokinet 2006

High-performance liquid chromatographic assay for carboplatin in ultrafiltered plasma combined with hyperbaric oxygenation

Yamazaki H, Tanaka K, Gamura S, Hashimoto T, Shimizu M — Drug Metab Pharmacokinet, 2006

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers developed a precise method to measure the chemotherapy drug carboplatin in human plasma, then used it to observe drug levels in patients who also received hyperbaric oxygen therapy.

What They Found

The new method showed high precision and accuracy, with less than 6% variation, a linear range from 0.1 to 80 microg/mL, and over 98% recovery. Using this method, they observed slightly higher plasma concentrations of carboplatin 30 minutes after a 60-minute hyperbaric oxygen therapy session than anticipated.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The findings are based on a very small number of patients, limiting the generalizability of the observations regarding carboplatin levels after hyperbaric oxygenation.

Was this summary helpful?

Study Details

Study Type Study
Category Uncategorised
Source Pubmed
PubMed ID 17072097
Year Published 2006
Journal Drug Metab Pharmacokinet
MeSH Terms Aged; Antineoplastic Agents; Carboplatin; Chromatography, High Pressure Liquid; Female; Humans; Hyperbaric Oxygenation; Infusions, Intravenous; Male; Middle Aged; Molecular Structure; Reproducibility of Results; Time Factors; Ultrafiltration

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.